The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Open accessAbstract
Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis. In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation. FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms. Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compound is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis. Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & Spiegel, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002759200 · Cited by 667
Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation.
Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., & Spiegel, S. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.1.155 · Cited by 640
Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., & Hoshino, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5037 · Cited by 596
FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540
Lysophospholipids--Receptor Revelations
Hla, T., Lee, M.-J., Ancellin, N., Paik, J. H., & Kluk, M. J. (2001) · Science · doi:10.1126/science.1065323 · Cited by 537
Molecular Cloning and Functional Characterization of Murine Sphingosine Kinase
Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R., & Spiegel, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23722 · Cited by 535
Olivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S., & Spiegel, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.545 · Cited by 518
Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway
Xia, P., Gamble, J. R., Rye, K.-A., Wang, L., Hii, C. S. T., Cockerill, P., Khew-Goodall, Y., Bert, A. G., Barter, P. J., & Vadas, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14196 · Cited by 407
Pinschewer, D. D., Ochsenbein, A. F., Odermatt, B., Brinkmann, V., Hengartner, H., & Zinkernagel, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5761 · Cited by 365
Self-citationPaik, J. H., Chae, S.-S., Lee, M.-J., Thangada, S., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009422200 · Cited by 286
Extracellular Export of Sphingosine Kinase-1 Enzyme
Ancellin, N., Colmont, C., Su, J., Li, Q., Mittereder, N., Chae, S.-S., Stefansson, S., Liau, G., & Hla, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102841200 · Cited by 280
Yanagawa, Y., Sugahara, K., Kataoka, H., Kawaguchi, T., Masubuchi, Y., & Chiba, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5493 · Cited by 260
Assessment of Animal Models for MS and Demyelinating Disease in the Design of Rational Therapy
Steinman, L. (1999) · Neuron · doi:10.1016/s0896-6273(00)81107-1 · Cited by 245
Gräler, M. H., Bernhardt, G., & Lipp, M. (1998) · Genomics · doi:10.1006/geno.1998.5491 · Cited by 232
Kiuchi, M., Adachi, K., Kohara, T., Minoguchi, M., Hanano, T., Aoki, Y., Mishina, T., Arita, M., Nakao, N., Ohtsuki, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000173z · Cited by 217
Mandala, S. M., Thornton, R., Galve-Roperh, I., Poulton, S., Peterson, C., Olivera, A., Bergstrom, J., Kurtz, M. B., & Spiegel, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120146897 · Cited by 193
Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E., & Baumruker, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.1 · Cited by 171
Self-citationMelendez, A., Floto, R. A., Gillooly, D. J., Harnett, M. M., & Allen, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9393 · Cited by 170
FTY720: ALTERED LYMPHOCYTE TRAFFIC RESULTS IN ALLOGRAFT PROTECTION
Brinkmann, V., Pinschewer, D. D., Feng, L., & Chen, S. (2001) · Transplantation · doi:10.1097/00007890-200109150-00002 · Cited by 169
Self-citationFTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
Brinkmann, V., Pinschewer, D., Chiba, K., & Feng, L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01419-4 · Cited by 163
Self-citationCloning and Characterization of Two Human Isozymes of Mg2+-independent Phosphatidic Acid Phosphatase
Kai, M., Wada, I., Imai, S.-I., Sakane, F., & Kanoh, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24572 · Cited by 159
CC Chemokine Receptor 7–dependent and –independent Pathways for Lymphocyte Homing
Henning, G., Ohl, L., Junt, T., Reiterer, P., Brinkmann, V., Nakano, H., Hohenberger, W., Lipp, M., & Förster, R. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1875 · Cited by 125
Self-citationEmmerling, M. R., Morganti-Kossmann, M. C., Kossmann, T., Stahel, P. F., Watson, M. D., Evans, L. M., Mehta, P. D., Spiegel, K., Kuo, Y., Roher, A. E., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06357.x · Cited by 96
How do neurons die in neurodegenerative diseases?
Kanazawa, I. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02017-2 · Cited by 60
Saland, J. M., Goode, M. L., Haas, D. L., Romano, T. A., & Seikaly, M. G. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.001003243.x · Cited by 53
EDG Receptors as a Therapeutic Target in the Nervous System
Beer, M. S., Stanton, J. A., Salim, K., Rigby, M., HEAVENS, R. P., Smith, D. W., & McAllister, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06544.x · Cited by 36
Miyamoto, T., Matsumori, A., Hwang, M., Nishio, R., Ito, H., & Sasayama, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01204-9 · Cited by 31
Cited by
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationOral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Metadata
- Authors
- Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M., & Lynch, K. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 24
- Pages
- 21453-21457
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2154089780
- Cited by
- 1,504
- References
- 32
- FWCI
- 19.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.